Jose Luis Piñana Sr.1*, David Valcarcel, MD2*, Rodrigo Martino3*, Francesc Fernandez4*, Pere Barba5*, Montserrat Rovira, MD, PhD6*, Enric Carreras, MD, PhD7*, Anna Sureda8* and Jorge Sierra, MD, PhD9*
1Hematology Clinical Division, Hospital de la santa creu i Sant Pau, Barcelona, Spain
2Hospital de la Santa Creu i Sant Pau (Edificio Nuevo), Barcelona, Italy
3Clinical Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
4Clinical Division of Hematology, hospital clinic de BArcelona, Barcelona, Spain
5Clinical Hematology, Hospital De Sant Pau, Barcelona, Spain
6GETH (Grupo Español de Trasplante Hematopoyético), PETHEMA (Programa Español de Tratamiento de Hemopatías Malignas), Barcelona, Spain
7GETH (Grupo Español de Transplante Hematopoyético), Hospital Clinic, Barcelona, Spain
8Hospital de Sant Pau, Hematology Department, Autonomous University of Barcelona, Barcelona, Spain
9Division of Clinical Hematology, Hospital de Santa Creu i Sant Pau, Barcelona, Spain